Oncogen
Bristol-Myers Science and Technology Group VP-Administration Bradley Simmons appointed to new position of president of the Bristol-Myers/Genetic Systems/Syntex cooperative cancer research partnership. Oncogen will continue under the scientific direction of George Todaro, MD . . . .
More from Archive
More from Pink Sheet
Office of Therapeutic Products Director Nicole Verdun and her deputy Rachael Anatol were escorted out of FDA headquarters on June 18. Disagreements over CAR-T regulation and Capricor’s DMD treatment may be to blame.
As Chief Medical and Scientific Officer, Vinay Prasad will advise the FDA Commissioner on cross-cutting issues, provide strategic leadership and be a public face of the agency.
Eisai and Lilly explain why they disagree with today’s conclusion by the health technology assessment institute, NICE, that the benefits of their respective drugs for Alzheimer’s disease are too small to justify the additional cost to the National Health Service.